Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group SURGERY Zhang, X., Wu, Z., Cloyd, J., Lopez-Aguiar, A. G., Poultsides, G., Makris, E., Rocha, F., Kanji, Z., Weber, S., Fisher, A., Fields, R., Krasnick, B. A., Idrees, K., Smith, P. M., Cho, C., Beems, M., Schmidt, C. R., Dillhoff, M., Maithel, S. K., Pawlik, T. M. 2019; 165 (3): 548–56
View details for DOI 10.1016/j.surg.2018.08.015
View details for Web of Science ID 000460845400008